And 2022 is looking like a bright year for international medical cannabis markets
But the company's CEO says it's already facing economic headwinds this year
But the firm acknowledges a market slowdown in Q4 it was 'not immune to'
Its majority shareholder Alcanna is set to be bought by Sundial for $346M at the end of March
The firm says the charges give it a 'clean slate' for future growth
The company continues to expand domestically and internationally
The company says it expects revenue from capital expenditure projects to ramp up this year
The firm says its performance in New Jersey has been strong, and is prepared for adult-use sales to launch there
The firm maintained positive adjusted EBITDA in every quarter last year
The Mary Jones brand is set to launch in California by the end of the month
The company says it's well positioned for domestic and international growth
After a reverse takeover and other business combinations, the firm's CEO says HYTN is on track for future growth
It's the firm's 8th consecutive quarter of positive cash flow from operations
The firm's annual losses reached US$396.1 million
But overall net income tripled to US$2.1M
With a business transition mostly complete, the firm says it expects strong growth in 2022
Company stock hit a 4-year low on Friday
The stalwart pot firm is projecting a return to EBITDA-positivity later this year, as it pivots to adult-use sales
Taking a recent majority stake in a baby food maker, Neptune joins other pot firms expanding broadly into different CPG categories
But sales for the firm's BioSteel sports drinks and Storz & Bickel vaporizers have been rising
In December, the firm finished a public offering for proceeds of $3.2 million
The firm reported its third-straight quarter of positive adjusted EBITDA
The company will be EBITDA-positive by Q3, CEO says
For better or for worse, the firm's focus appears to be moving further away from cannabis sales
A recent capital raise has boosted the firm's cash position
The company is also making a number of new changes to its top management
While it's now expanded to new markets, almost all of the firm's 2020 sales were in Quebec
After too-bleak an outlook in legal weed, the firm says it can better secure shareholder value via pharmaceutical development
The firm says opportunities lie in new genetics and its EU GMP-certified operations in Portugal
Early feedback on the firm's cannabis products has been strong
TGOD says new acquisitions and marketing partnerships will help boost sales
In October, the province started fulfillment and delivery from its distribution centre in St. John's
Company executives say the quarter was important for securing future growth
The firm's new CEO looks to be off to a strong start
Growth was driven by medical cannabis clinic operations in Colombia and Germany, company says
But other profitability metrics lagged in the quarter
The firm says it had its first EBITDA-profitable month in September
Delays to store openings and 'unforeseen' regulatory issues have caused the firm to rein in its earnings projections for the year
But net income soared due to a US$69M value gain on warrants
The firm blamed the drop in part on 'seasonal weakness'






































